Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

Baricitinib in patients with relapsing or naïve dermatomyositis (BIRD) Recruiting

2024-511899-32-00 Dermatomyositis; Baricitinib in patients with relapsing 2022-08-31
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-C… Recruiting

2022-502646-27-00 Relapsed or Refractory Diffuse Large B-Cell Lymphoma 2022-06-24
Preventive effect of Clopidogrel on the systemic sclerosis development risk Recruiting

2024-511005-39-00 Raynaud phenomenon 2022-06-22
Clinical study testing the efficacy and safety of Ravulizumab in pediatric patients with NMOSD Recruiting

2023-508534-33-00 Neuromyelitis Optica Spectrum Disorder (NMOSD) 2022-06-16
99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging, PROSTAM… Recruiting

2024-516083-28-00 Prostate cancer 2022-06-01
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes) Recruiting

2024-515275-35-00 Lyell syndrome 2022-05-13
A phase II-III randomized trial evaluating maintenance pembrolizumab (± pemetrexed) until progression versus observation (± pemetrexed) afte… Recruiting

2024-515945-40-00 Non small cell lung cancer 2022-05-02
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 2022-02-03
Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness Recruiting

2024-510798-84-00 Idiopathic sudden sensorineural hearing loss (ISSNHL) 2022-01-28
HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting

2024-516728-32-00 Indolent Systemic Mastocytosis and SSM 2021-10-29
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasth… Recruiting

2024-513854-31-00 Generalized Myasthenia Gravis 2021-10-27
Comparison of the efficacy and safety of rapamycin versus vigabatrin in the prevention of Tuberous Sclerosis Complex symptoms in infants in … Recruiting

2024-513068-25-00 Tuberous Sclerosis Complex, Epilepsy, Tumors associated 2021-05-20
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 2021-03-17
A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli… Recruiting

2024-512671-12-00 Unresectable head and neck squamous cell carcinoma, met 2021-03-05
Effectiveness and cost-effectiveness of Ozone therapy in patients with pain secondary to peripheral neuropathy induced by chemotherapy. Rand… Recruiting

2024-518021-16-00 Pain secondary to chemotherapy-induced peripheral neuro 2020-11-30
NeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced recta… Recruiting

2024-519007-10-00 Locally advanced stage II/III rectal cancer 2020-10-22
A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diab… Recruiting

2024-519687-40-00 diabetic foot syndrome 2020-09-11
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 2020-07-13
Trial comparing intra-discal allogeneic adult BM-MSC therapy and sham-treated controls in subjects with chronic low back pain due to lumbar … Recruiting

2023-510000-45-00 Degenerative Disc Disease 2020-07-12
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for… Recruiting

2024-511904-18-00 Pancreatic adenocarcinoma (PAC) 2020-07-08
An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficac… Recruiting

2024-519237-34-00 Treatment for Refractory Schizophrenia in Adults 2019-11-26
Tau and Amyloid PET imaging in normal aging, early Alzheimer's disease and related syndroms. Recruiting

2024-517074-17-00 Alzheimer's disease 2019-05-20
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting

2023-504201-36-00 Defined by parent protocol. The study will enroll all a 2018-12-21
A randomized trial to investigate the reset of humoral autoimmunity by combining belimumab with rituximab in severe systemic lupus erythemat… Recruiting

2023-507867-20-00 Lupus Erythematosus, Systemic 2018-10-04